NCT03937648

Study to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers

A Randomized, Double Blind, Placebo-controlled, Single-dose, Dose-escalation Study to Evaluate Pharmacokinetics, Safety, and Tolerability With Oral Administration of Ildong COL-144 Tablet in Korean Healthy Volunteers

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: IlDong Pharmaceutical Co Ltd · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A Randomized, Double blind, Placebo-controlled, Single-dose, Dose-escalation Study to Evaluate Pharmacokinetics, Safety, and Tolerability with Oral Administration of Ildong COL-144 tablet in Korean Healthy Volunteers

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	COL-144 50mg	COL-144 50mg
DRUG	COL-144 100mg	COL-144 100mg
DRUG	COL-144 200mg	COL-144 200mg
DRUG	COL-144 400mg	COL-144 400mg
DRUG	Placebo	Placebo

Timeline

• Start date: 2019-08-01
• Primary completion: 2019-10-31
• Completion: 2019-12-31
• First posted: 2019-05-06
• Last updated: 2019-05-06